Faculty Position - Department of Epidemiology and Cancer Control
St. Jude Children's Research Hospital
Summary
The Department of Epidemiology and Cancer Control at St. Jude Children's Research Hospital is recruiting Faculty Members at the FULL, ASSOCIATE or ASSISTANT level as we expand our Department's mission to conduct highly innovative clinical, biological, and population-health sciences research (both observational and interventional studies), and translate our findings into effective strategies to avert or mitigate cancer-treatment-related complications and improve the quality of life of childhood cancer survivors. We are seeking creative and collaborative scientists with vibrant research programs as we grow and further expand the mission.
Job description
Our research uses state-of-art approaches to assess/evaluate adverse outcomes and to design interventions to optimize health. Our Department and associated Cancer Center Programs in the St. Jude Comprehensive Cancer Center, include a diverse team of investigators with expertise in epidemiology/biostatistics, oncology/cardiology/neurology/nursing, genetics/bioinformatics, psychology/neuropsychology, exercise science/rehabilitation, symptoms/patient-reported outcomes, and health behavior/health services research.
We actively collaborate across Cancer Center Programs, engaging with both clinic- and laboratory-based researchers to advance clinical care and knowledge on childhood cancer and associated late effects, encompassing biological, clinical, and social determinants and mechanisms.
Our Department is home to both the Childhood Cancer Survivor Study with over 38,000 childhood cancer survivors diagnosed from 1970-1999 in North America, and the St. Jude Lifetime Cohort with over 6000 clinically assessed childhood cancer survivors treated at St. Jude Children's Research Hospital since 1962. These foundational studies are funded by the National Cancer Institute (NCI) and are unparalleled resources for research, with comprehensive characterizations of cancer treatment exposures/doses, whole genome/whole exome sequencing of germline genomes, patient-reported outcomes, and an extensive array of clinically-, laboratory- and survey-ascertained late effects outcomes and measurements.
Our Department encompasses a strong T32 Postdoctoral program, >130 staff members who supports maintaining and expanding activities of the two cohort studies and many ongoing R01-equivalent projects which are built on the two cohort studies.
Join us in the exciting, rewarding mission of improving lives of childhood cancer survivors through rigorous, cutting-edge research that has strong institutional support and commitment!
Successful applicants must hold a PhD, MD and/or equivalent degree, have at least three years of relevant postgraduate experience, and have a proven track record of productivity.
Requirements
- PhD, MD and/or equivalent degree
- At least three years of relevant postgraduate experience
- Proven track record of productivity
Benefits
- Competitive salary
- Generous start-up package
- Comprehensive benefit packages
Company overview
St. Jude Children's Research Hospital is a world-renowned pediatric research and treatment institution headquartered in Memphis, Tennessee, dedicated to advancing cures for childhood cancer and other catastrophic diseases. Founded in 1962 by entertainer Danny Thomas, it stands as the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted exclusively to children. The hospital operates on a unique funding model where families never receive bills for treatment, travel, housing, or food, with costs exceeding $2 billion annually primarily supported by donations through its fundraising organization ALSAC. St. Jude treats approximately 8,600 patients each year from all 50 states and around the world, with a focus on acute lymphoblastic leukemia, brain tumors, sickle cell disease, and infectious diseases. The institution employs over 7,000 staff members and maintains eight affiliate clinics across the United States. Through its St. Jude Global initiative, the hospital shares research and treatment protocols internationally, partnering with more than 350 institutions in over 90 countries. St. Jude has been instrumental in increasing childhood cancer survival rates from 20% in 1962 to over 80% today, while maintaining a robust research program that includes gene therapy, bone marrow transplantation, and precision medicine approaches.